No definition available.
Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)
C3_MARGINAL_ZONE_LYMPHOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
532 |
4. Check minimum number of eventsNone |
532 |
5. Include endpointsNone |
532 |
6. Filter based on genotype QC (FinnGen only) |
532 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 532 | 263 | 269 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.12 |
| Median age at first event (years) | 64.89 | 63.61 | 66.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 265
- Matched controls
- 2650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
285.9
220
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
578.5
113.7
105
*
XW000
NOMESCO Finland
Bone marrow biopsy
55.1
89.1
105
31
JN4BD
NOMESCO Finland
Extensive body CT
26.5
82.5
120
80
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
904.7
72.7
68
*
WF002
NOMESCO Finland
Radical radiotherapy
308.9
71.0
69
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
608.6
52.3
50
*
A03FA01
ATC
metoclopramide; systemic, rectal
10.4
49.5
110
169
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
44.0
41
*
JN4AD
NOMESCO Finland
Body CT examination
23.4
42.7
62
34
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
48.1
42.5
51
13
A04AA02
ATC
granisetron; systemic, transdermal
+∞
41.8
39
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
32.0
39.4
52
20
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
38.5
36
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
38.5
36
*
JN6AD
NOMESCO Finland
CT of torso and neck
82.6
38.2
42
6
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
151.6
37.8
39
*
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
37.4
35
*
H02AB02
ATC
dexamethasone; systemic
56.6
36.9
43
9
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
410.0
36.9
36
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.8
36.6
137
412
L03AA13
ATC
pegfilgrastim; parenteral
+∞
35.2
33
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
34.1
32
*
L03AA02
ATC
filgrastim; parenteral
+∞
34.1
32
*
XX3DW
NOMESCO Finland
Time consuming IT work
13.3
33.1
60
57
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
187.5
32.5
33
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
30.8
29
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
29.7
28
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
12.7
28.9
53
51
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
28.7
27
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
+∞
28.7
27
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
25.4
24
*
A04AA01
ATC
ondansetron; systemic, rectal
17.2
25.2
40
27
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
23.3
22
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
22.2
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
22.2
21
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
21.1
20
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
119.4
20.9
22
*
M04AA01
ATC
allopurinol; systemic
4.9
20.2
74
194
ZX120
NOMESCO Finland
Intravenous
6.7
20.2
54
97
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
+∞
20.0
19
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
20.0
19
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
20.2
19.6
29
16
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
19.0
18
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
19.0
18
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
41.7
18.9
23
6
WW500
NOMESCO Finland
Blood transfusion
15.9
18.6
30
21
1XC02
NOMESCO Finland
NA
47.7
18.5
22
5
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.5
18.0
40
54
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.9
17
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
17.9
17
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
192.2
17.7
18
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
67.9
17.0
19
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
67.9
17.0
19
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
16.8
16
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
16.8
16
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
16.8
16
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.8
15
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
15.8
15
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
15.8
15
*
PJA12
NOMESCO Finland
Sentinel node biopsy
169.5
15.6
16
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
15.2
114
523
130
Kela drug reimbursment
Malignant tumour
+∞
14.7
14
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
14.7
14
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
14.7
14
*
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
14.7
14
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.8
14.6
51
124
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
38.4
14.6
18
5
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.7
14.4
52
131
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
14.3
90
363
Z51.5
ICD-10 Finland
Palliative care
12.4
14.1
25
22
ZX112
NOMESCO Finland
Subcutaneous
32.0
14.1
18
6
C61
ICD-10 Finland
Malignant neoplasm of prostate
79.3
13.7
15
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
79.3
13.7
15
*
CAA30
NOMESCO Finland
Biopsy of orbit
+∞
13.7
13
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
11.9
13.3
24
22
WZC30
NOMESCO Finland
Teaching
4.5
13.2
49
127
R50.9
ICD-10 Finland
Fever, unspecified
4.0
13.0
56
167
CFA20
NOMESCO Finland
Biopsy of conjunctiva
52.7
13.0
15
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
12.9
58
179
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.6
12
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
136.1
12.5
13
*
A02BC02
ATC
pantoprazole; systemic
2.7
12.4
195
1342
JN4CD
NOMESCO Finland
Very extensive body CT
13.3
12.3
21
17
H02AB06
ATC
prednisolone; systemic
2.6
12.1
149
885
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
12.1
142
824
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
11.5
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
11.5
11
*
HA1AA
NOMESCO Finland
X-ray mammography
8.4
11.1
24
31
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
14.7
11.1
18
13
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
22.6
10.8
15
7
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.4
10.8
28
48
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.8
10.7
21
23
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
10.5
119
661
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
114.3
10.5
11
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
16.9
10.5
16
10
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
10.5
10
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
10.5
10
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.0
9.5
16
13
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
103.5
9.5
10
*
Z3231
NOMESCO Finland
Registered nurse
2.5
9.5
91
460
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
9.0
35
95
N02AA05
ATC
oxycodone; systemic
3.3
8.7
45
154
WX402
NOMESCO Finland
General anaesthesia
3.2
8.7
48
171
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
92.8
8.5
9
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
92.8
8.5
9
*
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
92.8
8.5
9
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
92.8
8.5
9
*
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
92.8
8.5
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
8.4
66
295
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.9
8.4
16
17
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
8.4
8
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
1AA09
NOMESCO Finland
NA
+∞
8.4
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
8.4
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.4
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
L01AA02
ATC
chlorambucil; oral
+∞
8.4
8
*
9699/3-C44.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of skin, NOS
+∞
8.4
8
*
H02AB07
ATC
prednisone; oral
2.9
8.3
52
203
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
8.3
57
236
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
8.2
40
131
GD1AD
NOMESCO Finland
Thorax CT examination
5.3
8.1
24
49
Z2221
NOMESCO Finland
Medical doctor
2.4
8.0
83
430
WX002
NOMESCO Finland
Sedation and analgesia
2.5
7.8
67
313
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
15.6
7.8
12
8
CBA10
NOMESCO Finland
Biopsy of eyelid
15.6
7.8
12
8
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.2
7.8
29
76
ZXA05
NOMESCO Finland
Left side
2.3
7.7
81
422
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.8
7.4
14
15
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
7.3
7
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
7.3
7
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
7.3
7
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
30.9
7.2
9
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
30.9
7.2
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.5
7.1
12
10
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.7
6.9
13
14
ZXE00
NOMESCO Finland
One hour or less
2.0
6.8
109
676
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.2
6.8
20
41
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
41.1
6.8
8
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
41.1
6.8
8
*
WX110
NOMESCO Finland
Local anesthesy
2.0
6.7
173
1287
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
71.4
6.5
7
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
71.4
6.5
7
*
J05AB11
ATC
valaciclovir; oral
2.8
6.4
41
162
B01AB05
ATC
enoxaparin; parenteral
2.1
6.4
86
492
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
6.4
104
646
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
6.4
107
674
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
18.5
6.3
9
5
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.3
6
*
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
27.4
6.3
8
*
ZX108
NOMESCO Finland
Inhalation
27.4
6.3
8
*
UJF32
NOMESCO Finland
Coloscopy
2.1
6.3
77
425
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
8.0
6.2
13
17
B01AB10
ATC
tinzaparin; parenteral
4.5
6.1
20
47
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
6.1
28
89
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
376
404
29.33
307.65
7.1
2.9
u/l
234.3
238.9
0.30
370
381
(4035726)
230
128
30.89
304.92
2.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
246
212
20.72
260.31
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
140
30
62.98
246.56
1.7
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
118
13
116.36
230.36
1.5
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
269
344
14.80
218.35
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
275
379
13.95
210.76
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
292
464
12.73
199.65
1.6
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
99
23
52.66
169.59
3.3
1.8
e9/l
1.2
1.1
0.11
69
13
(3005719) IgG [Mass/volume] in Serum or Plasma
216
289
11.90
165.31
4.0
2.2
g/l
9.2
10.8
3.49
207
266
(3042111) Morphology [Interpretation] in Bone marrow Narrative
116
55
26.69
159.66
1.9
1.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
80
19
49.38
135.68
2.6
1.9
%
14.8
11.3
—
29
9
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
74
17
50.40
126.26
2.7
2.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
68
11
70.73
124.14
3.5
1.4
e9/l
0.3
0.2
0.41
68
11
(3028026) IgM [Mass/volume] in Serum or Plasma
170
237
10.07
123.28
3.1
1.3
g/l
2.8
1.1
3.07
163
216
(42870588) Differential panel, method unspecified - Blood
380
1331
7.49
110.29
10.1
5.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
176
309
8.02
103.44
2.4
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
347
1186
6.54
101.07
4.1
2.4
umol/l
884.3
7237.2
3.68
339
1009
(3022096) Basophils/100 leukocytes in Blood
432
1821
8.30
98.86
11.4
5.3
%
0.7
0.7
0.14
421
1690
(3006504) Eosinophils/100 leukocytes in Blood
436
1871
8.37
97.26
11.7
5.4
%
2.8
3.0
0.87
426
1733
(3019069) Monocytes/100 leukocytes in Blood
435
1875
8.24
96.13
12.3
5.6
%
9.7
8.7
7.02
425
1745
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
86
62
16.35
95.96
5.8
5.6
iu/ml
590.6
132.1
—
18
9
(3001604) Monocytes [#/volume] in Blood
449
2023
8.82
93.56
10.6
5.1
e9/l
0.6
0.6
0.02
412
1751
(3002030) Lymphocytes/100 leukocytes in Blood
435
1905
8.04
93.43
11.9
5.5
%
28.6
27.2
1.26
424
1765
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
78
49
18.48
93.41
2.4
2.4
u/ml
11015.0
567.1
—
5
8
(3006315) Basophils [#/volume] in Blood
450
2037
8.84
93.12
10.6
5.2
e9/l
0.0
0.0
2.24
414
1769
(3019198) Lymphocytes [#/volume] in Blood
452
2067
8.89
92.07
10.7
5.2
e9/l
2.0
1.8
0.44
424
1820
(3018010) Neutrophils/100 leukocytes in Blood
429
1891
7.55
90.25
11.0
5.3
%
55.7
57.6
2.03
416
1760
(3013115) Eosinophils [#/volume] in Blood
453
2108
8.74
89.45
11.1
5.3
e9/l
0.2
0.2
1.75
420
1855
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
442
2069
7.72
84.72
13.4
3.7
umol/l
10.7
11.7
1.90
435
1937
(3013650) Neutrophils [#/volume] in Blood by Automated count
459
2238
8.66
83.62
22.0
6.2
e9/l
3.4
4.3
19.77
432
1959
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
52
16
35.91
81.67
4.1
1.7
e6/l
553.5
1279.7
—
27
6
(3023520) Reticulocytes [#/volume] in Blood
170
389
5.95
74.56
4.3
2.4
e9/l
74.6
68.8
0.87
148
308
(3027945) Reticulocytes/100 erythrocytes in Blood
196
512
5.48
73.96
4.4
2.2
%
1.9
1.8
0.67
185
459
(3020630) Protein [Mass/volume] in Serum or Plasma
161
354
6.09
73.66
2.6
1.6
g/l
66.0
67.8
1.59
150
316
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
50
21
26.18
70.76
4.4
2.4
%
29.6
46.7
—
26
8
(3024561) Albumin [Mass/volume] in Serum or Plasma
389
1812
5.27
69.27
7.5
3.5
g/l
35.1
35.5
0.86
374
1676
(3017181) Myelocytes/100 leukocytes in Blood
146
314
6.03
67.98
6.6
3.9
%
0.6
0.8
0.30
73
65
(3037756) Immunofixation for Serum or Plasma
73
77
10.83
63.62
1.3
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
92
133
8.15
62.62
2.1
1.4
mg/l
23.1
31.5
1.71
82
108
(3034860) Kappa light chains.free [Mass/volume] in Serum
92
133
8.15
62.62
2.2
1.4
mg/l
51.0
42.7
0.38
80
109
(3002179) Metamyelocytes/100 leukocytes in Blood
135
291
5.88
62.34
6.5
3.9
%
0.5
0.5
0.08
53
53
(3012095) Magnesium [Moles/volume] in Serum or Plasma
197
599
4.63
60.19
5.9
2.6
mmol/l
0.8
0.8
1.36
191
549
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
78
99
9.06
59.04
1.9
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
62
59
11.76
57.85
1.5
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
131
299
5.49
56.41
7.0
4.0
%
0.1
0.1
0.37
67
57
(40760888) Immunoglobulin light chains.free panel - Serum
76
100
8.70
55.79
2.1
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
402
2133
4.62
54.79
9.8
5.4
mmol/l
1.2
1.2
0.84
339
1815
(40768804) Tissue Pathology biopsy report
300
1303
3.99
54.68
2.6
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
87
140
7.23
53.53
2.7
1.4
g/l
2.0
0.5
2.02
78
120
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
172
6.59
53.28
2.6
1.4
g/l
7.0
7.8
2.79
76
123
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
96
172
6.59
53.28
2.6
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
57
56
11.28
51.95
1.5
1.4
u/ml
107.2
109.2
—
20
6
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
162
6.66
51.89
2.7
1.4
g/l
3.1
3.1
0.02
73
122
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
172
6.42
51.00
2.6
1.4
g/l
3.6
3.9
0.48
71
120
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
160
6.39
47.94
2.7
1.4
g/l
10.3
10.5
0.07
76
131
(3025159) Blasts/100 leukocytes in Blood
119
286
5.07
47.77
6.7
4.1
%
0.0
1.6
0.49
57
54
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
366
1951
3.81
46.28
8.3
5.0
mmol/l
1.2
1.2
1.37
358
1730
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
52
56
10.18
44.31
2.9
2.1
pg
33.9
33.2
0.42
52
56
(3016228) CD19 cells/100 cells in Blood
49
7
76.77
43.82
2.6
1.6
%
8.6
3.1
—
49
7
(21494814) CD8 cells/100 lymphocytes in Specimen
49
7
76.77
43.82
2.6
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
45
41
11.90
42.96
5.7
3.3
%
1.0
1.1
0.05
37
32
(3007164) IgA [Mass/volume] in Serum or Plasma
201
762
3.63
42.91
2.2
1.3
g/l
1.9
2.8
6.06
158
438
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
60
81
8.22
42.85
2.1
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
253
1111
3.44
42.72
7.6
3.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
288
1379
3.37
41.98
6.0
2.0
mmol/l
2.4
2.4
0.10
269
1131
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
52
62
9.19
41.01
1.5
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
268
1246
3.32
40.71
7.3
3.2
ph
7.4
7.4
0.15
72
218
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
61
89
7.61
40.71
2.0
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
50
60
9.09
39.20
2.1
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
42
5
91.09
38.40
2.6
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
477
3245
5.55
38.23
18.6
5.3
u/l
80.5
75.7
2.20
471
2969
(3002256) Pathology report gross observation
111
300
4.41
37.99
1.5
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
327
1816
3.08
34.74
18.7
8.6
e9/l
0.0
0.0
0.11
290
1501
(40760892) CBC W Ordered Manual Differential panel - Blood
204
874
3.16
34.45
8.7
4.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
32
0
+∞
33.70
1.1
0.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
68
138
5.50
32.63
2.3
3.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
62
7.84
31.42
1.6
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
203
907
3.00
31.32
16.0
4.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
169
689
3.13
30.56
2.8
1.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
32
29
11.68
30.49
7.0
3.3
%
48.7
47.6
0.06
21
21
(21494434) Karyotype in Bone marrow
37
42
9.39
30.14
1.1
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
462
3274
4.12
30.05
7.9
4.2
mm/h
17.4
12.5
5.92
448
2985
(3008757) Leukocyte morphology finding [Identifier] in Blood
34
35
10.31
29.73
6.8
3.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
317
1842
2.78
29.03
6.1
3.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
86
239
4.10
27.95
2.3
1.4
ug/l
3.0
4.0
0.34
61
186
(40765096) Chromosome analysis panel by Banding
34
9
40.23
27.42
1.5
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
306
1784
2.68
27.23
7.8
9.7
inr
1.1
1.3
8.22
93
525
(3033658) Prothrombin time (PT) actual/Normal
200
969
2.70
25.54
5.4
3.4
%
86.0
87.3
0.32
190
939
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
35
46
8.07
25.35
1.7
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
29
31
9.84
24.62
1.4
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
128
498
3.07
24.54
2.5
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
228
1201
2.57
24.29
4.1
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
37
8.83
24.23
2.3
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
38
58
6.98
24.15
1.2
1.2
u/ml
268.0
286.7
0.11
23
34
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
16
14.30
23.77
3.5
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
29
33
9.24
23.50
2.1
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
126
497
3.01
23.49
2.5
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
35
51
7.28
23.18
1.7
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
48
7.50
23.15
1.7
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
22
17
13.46
22.97
2.3
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
22
17
13.46
22.97
2.3
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
22
17
13.46
22.97
2.3
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
22
17
13.46
22.97
2.3
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
27
6
47.24
22.57
4.8
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
36
57
6.70
22.09
2.0
2.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
68
188
4.00
22.09
4.2
1.7
g/l
1.4
1.5
0.16
57
166
(3018677) aPTT in Platelet poor plasma by Coagulation assay
146
643
2.75
22.04
2.8
1.8
s
29.9
29.5
0.34
139
623
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
38
64
6.32
21.98
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
42
79
5.69
21.72
1.5
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
135
580
2.78
21.31
2.4
2.3
g/l
2.2
2.3
0.92
125
537
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
185
932
2.51
21.09
3.7
2.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
128
543
2.79
20.64
2.5
2.4
%
23.4
23.7
0.04
111
463
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
35
61
6.07
19.55
1.3
1.3
miu/ml
144.2
273.0
—
8
23
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
30
45
7.01
19.32
1.9
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
28
39
7.52
19.25
1.4
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
24
28
8.93
19.03
2.3
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
28
8.93
19.03
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
41
86
5.08
18.79
1.3
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
137
636
2.55
18.23
2.6
2.3
umol/l
13.1
13.4
0.13
129
583
(3013826) Glucose [Moles/volume] in Serum or Plasma
365
2574
2.33
18.06
5.7
4.4
mmol/l
6.6
6.8
1.66
355
2400
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
24
32
7.81
17.09
2.2
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
24
32
7.81
17.09
2.2
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
24
32
7.81
17.09
2.2
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
103
428
2.74
17.04
3.9
2.3
umol/l
5.8
6.9
0.82
95
372
(3002582) Erythrocytes [#/volume] in Urine
212
1248
2.16
15.90
3.8
3.0
e6/l
39.2
105.6
0.64
164
953
(3018095) Leukocytes [#/volume] in Urine
237
1474
2.10
15.23
4.5
3.5
e6/l
55.3
91.6
0.92
168
1032
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
9
24.22
15.21
2.2
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
9
24.22
15.21
2.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
9
24.22
15.21
2.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
192
1103
2.16
15.19
3.7
2.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
32
65
5.17
15.18
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
84
333
2.81
15.11
1.8
1.8
g/l
0.2
0.2
0.97
74
294
(3047189) Immunofixation for 24 hour Urine
14
10
14.35
15.09
1.2
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
29
55
5.52
14.82
1.9
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
196
1149
2.12
14.60
3.7
3.0
e6/l
0.3
0.4
1.23
144
853
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
19
23
8.53
14.59
1.6
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
19
23
8.53
14.59
1.6
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
188
1100
2.10
13.96
2.4
2.2
mg/l
3.1
3.0
0.22
169
927
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
19
9.21
13.84
2.3
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
17
19
9.21
13.84
2.3
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
270
2.88
13.76
2.7
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
25
45
5.78
13.48
1.5
1.3
g/l
7.0
6.3
0.18
17
31
(3024139) IgG subclass 3 [Mass/volume] in Serum
25
45
5.78
13.48
1.5
1.3
g/l
0.3
0.3
0.10
17
31
(4062490)
25
45
5.78
13.48
1.6
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
25
45
5.78
13.48
1.5
1.3
g/l
1.9
2.6
0.88
18
31
(3024980) IgG subclass 4 [Mass/volume] in Serum
30
64
4.91
13.46
1.7
1.7
g/l
0.4
0.8
1.22
21
49
(3042936) Bacteria identified in Isolate by Culture
121
603
2.30
13.37
2.0
1.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
23
39
6.12
13.16
1.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
127
652
2.25
13.04
3.0
2.8
e6/l
2.1
2.1
0.02
68
344
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
28
58
5.04
12.99
1.1
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
36
93
4.08
12.74
1.9
1.7
u/ml
44.3
142.0
0.54
31
72
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
22
7.95
12.35
1.7
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
25
7.42
12.34
1.2
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
262
1784
1.92
12.22
2.6
2.2
nmol/l
80.5
78.3
0.51
245
1541
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
75
4.33
11.95
4.9
3.3
%
56.4
58.9
0.36
31
75
(3031040) Bacteria [#/volume] in Urine by Automated count
365
2788
1.98
11.91
5.6
4.3
e6/l
2356.1
3471.7
—
7
41
(3037467) Urinalysis macro (dipstick) panel - Urine
381
2956
2.02
11.86
5.2
4.2
—
—
—
0
0
(3026782) Osmolality of Urine
143
797
2.09
11.79
3.2
2.5
mosm/kgh2o
516.6
546.5
1.00
128
668
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
33
6.26
11.74
2.1
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
230
1518
1.91
11.63
4.2
3.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
25
6.99
11.08
2.3
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
118
3.49
11.03
2.7
3.0
u/ml
0.3
0.4
0.85
26
70
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
92
442
2.31
10.93
4.4
3.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
100
3.68
10.78
1.1
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
75
331
2.47
10.76
6.3
7.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
149
869
1.99
10.72
3.2
2.3
e6/l
5.0
5.3
0.16
134
756
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
17
8.43
10.66
2.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
17
8.43
10.66
2.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
152
895
1.98
10.63
3.4
4.1
ng/l
269.2
364.0
0.19
124
731
(40768806) Pleura Pathology biopsy report
16
23
7.14
10.62
2.3
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
129
717
2.05
10.59
2.8
2.6
e6/l
0.9
1.1
0.30
68
408
(3001122) Ferritin [Mass/volume] in Serum or Plasma
251
1740
1.84
10.59
3.4
2.6
ug/l
283.4
131.3
3.81
235
1572
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
12
10.21
10.47
1.3
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
29
74
4.09
10.44
4.4
3.0
e9/l
3.2
4.5
3.75
29
74
(3003694) ABO and Rh group [Type] in Blood
166
1016
1.92
10.31
1.6
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
8
19.24
10.31
3.6
2.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
12
13
9.42
9.90
1.3
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
113
614
2.07
9.80
1.8
1.2
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
15
22
6.99
9.78
1.9
1.0
u/l
214.1
354.3
0.65
15
22
(3019225) pH of Specimen
91
459
2.19
9.56
5.8
3.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
75
350
2.33
9.48
2.2
2.1
u/l
29.4
45.9
0.68
61
289
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
14
8
17.93
9.44
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
15
23
6.68
9.40
1.3
2.1
—
—
—
0
0
(44790049)
20
41
5.03
9.38
1.4
1.4
—
—
—
0
0
(44790047)
20
41
5.03
9.38
1.4
1.4
—
—
—
0
0
(44806118)
20
41
5.03
9.38
1.4
1.4
—
—
—
0
0
(44790048)
20
41
5.03
9.38
1.4
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
15
24
6.40
9.03
2.1
2.8
u/ml
3407.3
1372.7
0.81
15
24
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
12
5
24.48
8.94
1.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
15
8.16
8.89
2.2
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
15
8.16
8.89
2.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
36
120
3.15
8.75
1.8
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
58
257
2.41
8.22
2.0
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
190
1284
1.75
8.21
6.4
2.6
u/l
28.3
34.9
2.24
182
1218
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
481
4262
2.34
7.98
34.7
13.0
mg/l
21.7
23.7
0.62
453
3307
(3049717) Cytology report of Urine Cyto stain
38
139
2.87
7.88
2.4
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
190
1298
1.72
7.83
4.0
3.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
56
251
2.38
7.74
2.0
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
53
4.08
7.68
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
29
5.29
7.49
2.3
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
33
4.97
7.45
1.3
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
57
262
2.32
7.44
3.2
2.8
e9/l
3.8
3.9
0.06
44
185
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
49
216
2.40
7.03
5.3
9.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
31
108
2.99
7.02
1.6
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
142
919
1.74
6.98
1.8
1.6
mg/l
1.6
1.2
1.03
114
705
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
44
4.20
6.86
3.5
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
37
144
2.69
6.85
2.5
2.7
g/l
0.9
0.3
0.62
20
45
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
40
162
2.59
6.85
3.1
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
10
6
16.95
6.76
3.2
1.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
45
4.11
6.67
3.5
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
45
4.11
6.67
3.5
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
64
3.54
6.63
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
34
130
2.73
6.52
1.4
1.2
u/ml
2.2
3.1
0.47
11
18
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
46
4.02
6.49
3.5
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
46
4.02
6.49
3.5
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
46
4.02
6.49
3.5
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
96
570
1.83
6.25
1.3
1.3
titre
1012.9
586.2
0.88
28
139
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
34
133
2.66
6.25
1.4
1.2
u/ml
1.8
8.2
0.90
14
21
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
35
139
2.62
6.24
1.4
1.2
u/ml
46.3
21.8
—
9
7
(3028308) Erythrocytes [#/volume] in Pleural fluid
14
30
4.77
6.24
1.6
1.1
e6/l
13766.7
21613.7
—
6
16
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
19
5.89
6.13
1.3
2.1
nmol/l
1.9
3.3
0.87
11
19
(3023199) Leukocytes [#/volume] in Pleural fluid
15
35
4.38
6.06
1.5
1.1
e6/l
1167.4
2549.7
—
8
23
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
190
1375
1.59
5.91
2.8
2.1
u/l
56.4
57.0
0.08
174
1254
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
49
234
2.21
5.86
4.6
7.9
mmol/l
25.5
25.1
0.24
49
234
(3019309) Folate [Moles/volume] in Red Blood Cells
140
945
1.65
5.76
1.9
1.8
nmol/l
1179.3
1205.6
0.12
111
711
(3016502) Oxygen saturation in Arterial blood
80
465
1.85
5.56
5.2
6.4
%
96.9
95.2
2.87
75
451
(3045788) Cell count panel - Pleural fluid
12
25
4.89
5.52
1.4
1.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
86
516
1.80
5.39
5.3
6.2
kpa
13.3
11.5
2.14
81
500
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
86
516
1.80
5.39
5.3
6.2
kpa
5.1
5.1
0.06
81
499
(3044889) 12 lead EKG panel
367
3119
1.57
5.36
4.4
4.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
86
518
1.79
5.32
5.2
6.2
mmol/l
1.4
1.5
0.04
70
400
(40761536) Microorganisms panel - Urine sediment
63
344
1.94
5.29
4.5
3.7
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
19
59
3.30
5.22
1.4
1.3
pmol/l
118.4
62.4
1.44
19
59
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
35
4.08
5.20
2.8
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
198
2.22
5.19
1.5
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
31
4.27
5.12
1.6
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
9
10.15
5.04
2.3
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
23
4.86
5.03
1.3
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
70
404
1.84
4.97
4.6
3.3
mmol/l
1.8
2.1
0.23
59
326
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
56
3.29
4.93
1.2
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
160
1156
1.55
4.85
1.7
1.5
nmol/l
20.3
20.9
0.19
146
965
(40768443) Skin Pathology biopsy report
35
158
2.30
4.80
1.5
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
28
114
2.54
4.79
1.7
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
454
4102
1.73
4.78
30.1
11.9
ml/min/173m2
76.7
76.5
0.08
423
3298
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
33
4.01
4.73
1.1
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
12
29
4.21
4.65
1.1
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
35
161
2.26
4.60
1.9
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
87
2.72
4.55
1.6
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
78
479
1.74
4.50
1.8
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
246
1971
1.46
4.42
2.3
2.0
pmol/l
92.7
95.0
0.30
148
992
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
193
1475
1.48
4.41
2.9
3.0
ng/l
1652.4
1371.8
0.42
169
1246
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
151
2.26
4.40
2.4
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
26
4.30
4.37
1.1
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
6
11.80
4.28
1.6
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
6
11.80
4.28
1.0
2.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
84
2.69
4.28
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
84
2.69
4.28
1.6
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
24
96
2.57
4.27
3.4
2.3
mg/l
1.7
1.7
0.18
24
85
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
319
2700
1.45
4.21
3.6
2.9
u/l
49.6
46.9
0.28
295
2476
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26
109
2.46
4.21
1.3
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
27
4.14
4.18
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
63
2.92
4.10
1.2
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
68
413
1.74
4.08
2.1
3.2
ng/l
306.0
196.9
0.71
63
385
(3035350) Ketones [Presence] in Urine by Test strip
256
2090
1.43
4.05
3.8
3.6
estimate
0.0
0.0
0.00
70
368
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
14
6.52
4.00
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
18
64
2.88
3.99
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
38
3.48
3.92
2.5
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
16
54
3.02
3.88
1.5
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
11
7.36
3.87
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
89
2.54
3.85
3.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
50
282
1.85
3.83
5.7
3.5
mmol/l
1.3
2.0
0.60
37
210
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
25
4.06
3.71
1.5
1.3
ug/l
22.5
15.1
—
10
25
(3009261) Glucose [Presence] in Urine by Test strip
256
2113
1.41
3.70
4.0
3.6
estimate
0.0
0.0
0.50
70
357
(3023419) Bacteria identified in Sputum by Culture
18
68
2.70
3.60
2.1
2.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
80
2.56
3.58
1.2
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
51
296
1.80
3.58
5.8
3.6
ph
7.4
7.4
—
7
36
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
9
7.86
3.57
1.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
9
7.86
3.57
1.1
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
252
2084
1.40
3.55
5.3
4.9
estimate
0.0
0.0
0.00
68
357
(3019832) Treponema pallidum Ab [Presence] in Serum
36
187
1.99
3.53
1.6
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
8
13
6.23
3.51
2.1
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
267
2233
1.39
3.51
2.9
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
78
514
1.61
3.45
1.9
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
33
168
2.03
3.42
1.4
1.6
—
121.8
—
0
11
(3022313) Gas panel - Capillary blood
40
220
1.88
3.33
5.1
3.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
149
2.07
3.32
1.6
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
52
314
1.73
3.21
3.9
4.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
11
6.43
3.19
2.4
2.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
387
4212
0.70
3.16
5.7
6.5
mmol/mol
39.8
40.6
0.89
350
3880
(3000492) Spirometry study
57
355
1.68
3.15
1.7
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
39
3.12
3.10
1.2
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
33
175
1.94
3.07
2.0
2.2
ug/l
138.0
579.6
1.03
33
161
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
29
3.50
3.06
1.1
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
26
128
2.08
2.96
1.4
1.6
iu/ml
7.1
0.1
—
7
26
(3009871) Measles virus Ab [Titer] in Serum
6
9
6.73
2.87
1.7
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
47
2.81
2.83
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
413
3778
1.42
2.83
32.2
14.1
%
37.6
39.8
4.00
273
2446
(3022145) Colonoscopy Study observation
65
439
1.55
2.61
1.4
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
7
7.20
2.55
1.6
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
11
5.50
2.55
1.5
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
50
2.64
2.55
1.2
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
95
2.15
2.52
4.1
2.1
g/l
117.3
133.5
1.92
11
71
(3021901) Oxygen saturation in Capillary blood
18
82
2.24
2.50
4.9
2.6
—
—
—
0
0
(4281824)
8
21
3.85
2.47
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
48
307
1.62
2.43
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
12
5.04
2.41
1.0
1.9
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
8
6.30
2.37
1.6
1.7
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
17
4.16
2.36
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
17
4.16
2.36
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
17
4.16
2.36
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
17
4.16
2.36
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
217
1838
1.31
2.33
3.8
3.8
ng/l
21.4
40.3
4.77
168
1348
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
53
352
1.56
2.30
5.2
3.7
ng/l
94.3
83.3
0.39
48
309
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
53
2.49
2.29
2.6
3.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
21
106
2.02
2.28
2.7
3.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
18
3.93
2.26
1.3
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
18
3.93
2.26
1.1
1.1
—
—
—
0
0
(3015736) pH of Urine
198
1667
1.30
2.20
3.3
3.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
30
3.03
2.15
1.7
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
30
3.03
2.15
1.7
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
43
2.59
2.11
1.5
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
116
1448
0.75
2.08
2.7
3.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
10
5.04
2.07
1.8
1.3
iu/ml
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
112
876
1.35
2.07
1.3
1.3
u/ml
4.1
1.7
0.51
24
236
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
38
2.66
2.02
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
38
2.66
2.02
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
38
2.66
2.02
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
75
551
1.42
2.02
1.2
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
360
3293
1.29
2.00
3.9
3.8
pmol/l
14.8
15.0
0.89
331
2941
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
113
1.89
1.94
1.5
1.4
ug/g
259.5
309.0
0.61
16
66
(4027681)
8
27
2.99
1.94
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
97
750
1.36
1.93
1.3
1.3
iu/ml
64.4
37.2
0.89
36
229
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
39
2.59
1.93
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
39
2.59
1.93
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
39
2.59
1.93
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
17
3.56
1.84
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
17
3.56
1.84
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
30
471
0.62
1.84
1.4
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
47
2.37
1.78
1.2
1.1
—
—
—
0
0
(3013512) EKG study
170
1437
1.27
1.77
4.3
4.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
81
2.01
1.76
1.1
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
18
3.36
1.75
1.3
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
18
3.36
1.75
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
96
1.91
1.72
1.2
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
13
3.87
1.72
2.8
5.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
19
3.18
1.66
1.2
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
19
3.18
1.66
6.0
1.4
u/l
203.0
206.9
—
6
19
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
273
1.50
1.59
1.4
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
27
168
1.64
1.58
1.9
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
85
1.91
1.56
5.1
3.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
33
2.45
1.54
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
140
1648
0.80
1.53
4.1
4.0
mg/mmol
12.8
7.8
0.35
88
1045
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
51
2.18
1.51
1.1
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
38
2.39
1.46
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
28
2.52
1.45
2.4
2.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
418
4380
0.79
1.44
4.1
4.8
mmol/l
1.4
1.5
3.96
372
3985
(40768441) Liver Pathology biopsy report
6
22
2.75
1.44
1.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
432
4507
0.78
1.41
4.7
5.5
mmol/l
2.6
2.7
1.44
385
4110
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
423
4420
0.79
1.36
4.2
4.9
mmol/l
4.4
4.6
1.67
378
4046
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
39
275
1.45
1.35
1.4
1.3
—
42.7
—
0
15
(40761511) CBC panel - Blood by Automated count
467
4490
1.33
1.35
26.8
12.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
9
42
2.16
1.34
1.7
1.5
mosm/kgh2o
274.4
269.8
—
9
26
(3029937) Albumin [Presence] in Urine by Test strip
135
1151
1.23
1.27
4.4
3.9
estimate
0.0
0.0
0.50
69
354
(3002523) Influenza virus A Ag [Presence] in Specimen
9
44
2.06
1.27
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
44
2.06
1.27
1.2
1.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
16
92
1.76
1.26
2.8
4.6
kpa
5.1
5.1
0.07
16
92
(3021387) Prolactin [Units/volume] in Serum or Plasma
13
70
1.88
1.25
2.1
1.7
mu/l
341.5
274.6
0.35
13
64
(3011397) Hemoglobin [Presence] in Urine by Test strip
121
1024
1.24
1.22
3.7
3.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
16
93
1.74
1.22
2.8
4.6
kpa
8.6
8.2
0.35
16
93
(40767503) Oxygen content in Capillary blood by calculation
16
93
1.74
1.22
5.0
2.8
%
14.2
16.2
—
9
44
(21494755) Public health laboratory ask at order entry panel
16
262
0.60
1.22
1.4
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
19
2.65
1.22
1.0
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
78
628
1.28
1.20
25.0
26.3
inr
1.2
1.3
0.30
12
96
(3024928) Oxygen saturation in Venous blood
16
94
1.72
1.18
3.8
3.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
130
0.46
1.17
1.3
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
30
2.35
1.12
2.0
2.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
51
1.98
1.12
1.5
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
127
1092
1.21
1.10
3.9
3.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
35
253
1.41
1.09
2.5
2.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
(4268621)
8
41
1.97
1.09
2.5
2.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
82
1.73
1.06
1.4
1.9
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
33
2.14
1.06
1.0
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
165
1461
1.19
1.04
2.1
2.2
u/l
211.6
269.3
0.33
154
1370
(3012516) Albumin [Mass/volume] in Urine
138
1568
0.84
1.01
3.5
3.3
mg/l
2933.9
233.1
1.89
95
995
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
35
2.01
1.00
1.9
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
87
728
1.23
0.99
1.2
1.3
u/ml
6.5
14.8
1.37
30
268
(4211845)
5
23
2.18
0.98
2.2
3.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
142
1605
0.84
0.98
3.3
3.1
mmol/l
7.3
7.5
0.37
119
1338
(3011648) Oxygen content in Venous blood
7
36
1.96
0.97
4.0
2.1
%
9.1
10.2
—
7
36
(3004616) Nuclear Ab [Presence] in Serum
11
62
1.79
0.95
1.5
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
70
1.73
0.93
2.7
2.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
29
2.08
0.89
1.2
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
88
1.61
0.85
1.3
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
489
4783
1.28
0.80
47.5
19.0
e12/l
4.3
4.5
13.91
483
4618
(3022621) pH of Urine by Test strip
37
287
1.31
0.79
3.1
2.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
489
4784
1.27
0.78
47.6
19.0
e9/l
6.6
6.7
0.23
483
4621
(3006653) Thiamine [Moles/volume] in Blood
0
26
0.00
0.78
0.0
1.0
—
149.2
—
0
26
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
411
4248
0.86
0.76
3.7
4.3
mmol/l
1.3
1.3
0.17
364
3834
(4306422)
9
53
1.71
0.75
1.6
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
24
2.09
0.74
1.2
2.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
38
1.85
0.73
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
488
4780
1.25
0.72
47.8
19.0
e9/l
219.9
244.6
11.18
482
4627
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
41
1.72
0.70
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
415
4012
1.16
0.69
4.9
4.7
mu/l
2.0
2.3
0.51
383
3601
(4034850)
12
180
0.66
0.69
7.0
10.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
43
1.64
0.67
1.6
1.1
—
85.4
—
0
5
(3011288) Drugs identified in Urine by Screen method
7
44
1.60
0.65
1.3
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
189
0.68
0.65
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
176
1622
1.13
0.63
4.3
3.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
117
1051
1.15
0.62
1.6
1.8
pmol/l
501.7
29384327.6
1.26
95
844
(3030981) Hyaline casts [#/volume] in Urine by Automated count
28
218
1.30
0.61
3.3
2.3
e6/l
0.5
0.2
0.77
28
212
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
105
938
1.15
0.60
2.9
2.7
ug/l
0.8
0.8
0.23
71
623
(44806420)
0
20
0.00
0.60
0.0
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
97
1.46
0.59
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
53
1.52
0.58
1.1
1.1
—
—
—
0
0
(4024509)
6
35
1.72
0.58
1.0
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
30
239
1.27
0.56
1.2
1.2
iu/ml
150.0
110.6
—
9
98
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
116
1.39
0.55
1.7
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
116
1.39
0.55
1.7
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
66
1.53
0.53
1.2
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
117
1.38
0.53
1.7
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
29
234
1.25
0.50
3.6
2.7
mmol/l
24.7
25.3
0.43
29
228
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
278
0.78
0.49
1.9
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
33
272
1.23
0.48
2.1
2.2
nmol/l
13.8
15.1
0.33
28
236
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
365
1.19
0.48
2.8
2.2
ml/min/173m2
48.0
64.1
1.74
17
140
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
10
68
1.48
0.47
1.4
1.5
%
51.8
73.1
—
5
45
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
48
1.46
0.47
1.7
1.5
—
—
—
0
0
(4010399)
41
349
1.19
0.45
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
174
0.74
0.44
1.1
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
56
1.44
0.42
1.1
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
33
1.52
0.41
1.0
1.1
—
5.7
—
0
7
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
11.1
—
942.7
—
0
16
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
13.1
—
1751.3
—
0
16
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
10.6
—
0.6
—
0
17
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
60
1.34
0.40
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
55
486
1.15
0.39
1.4
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.1
—
205.2
—
0
19
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
68
1.33
0.37
2.9
2.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
9
68
1.33
0.37
2.9
2.3
mmol/l
105.7
105.0
—
9
68
(3041354) Potassium [Moles/volume] in Venous blood
9
68
1.33
0.37
2.9
2.3
mmol/l
4.2
4.1
—
9
68
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
98
1.33
0.37
4.0
3.8
mg/l
25.4
25.9
—
8
67
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
116
1.30
0.37
1.1
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
447
4392
1.11
0.37
4.9
5.0
mmol/l
5.9
6.1
1.66
404
3962
(40761535) Cells panel - Urine sediment
34
394
0.85
0.36
4.7
3.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
114
1223
0.91
0.35
1.8
1.7
mmol/l
1.4
1.4
0.03
97
1003
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
7
52
1.35
0.31
1.0
1.0
g/l
1.7
1.5
—
7
44
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
138
1.24
0.31
1.9
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
55
1.28
0.30
1.4
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
1.1
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
167
1.21
0.29
1.6
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
50
451
1.12
0.28
1.8
2.2
ug/g
197.5
139.3
0.68
44
354
(3016879) Cocaine [Presence] in Urine
8
65
1.23
0.27
1.1
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
91
972
0.92
0.26
4.3
3.9
kg/l
1.0
1.0
0.11
19
141
(3000330) Specific gravity of Urine by Test strip
27
235
1.16
0.26
3.0
3.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
77
1.17
0.24
1.3
1.5
—
—
—
0
0
(4094501)
16
134
1.20
0.23
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(4198724)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
10
0.00
0.21
0.0
6.5
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
13
0.00
0.21
0.0
6.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
13
0.00
0.21
0.0
6.3
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
14
0.00
0.20
0.0
5.6
—
24.7
—
0
14
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
59
633
0.92
0.20
8.1
6.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
113
0.79
0.20
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
50
1.20
0.19
1.3
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
53
1.13
0.18
1.2
2.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
26
233
1.12
0.18
1.2
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
62
1.13
0.17
1.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
68
1.18
0.16
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
69
1.16
0.16
1.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
70
1.15
0.16
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
70
1.15
0.16
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
45
420
1.08
0.15
1.4
1.8
%
1.4
1.6
0.69
39
355
(1761482) Bacteria [#/volume] in Urine by Culture
14
121
1.16
0.15
4.0
4.5
—
—
—
0
0
(3020891) Body temperature
18
202
0.89
0.14
4.2
4.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
60
632
0.94
0.13
4.0
5.1
%
30.6
32.4
0.71
38
407
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
187
0.91
0.10
1.4
1.8
—
—
—
0
0
(1002224) Polysomnography panel
14
156
0.89
0.10
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
171
1677
1.03
0.09
4.6
3.9
ug/l
2.3
2.0
0.83
153
1488
(3014051) Protein [Presence] in Urine by Test strip
11
97
1.14
0.09
2.4
2.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
7
66
1.06
0.08
1.1
1.3
—
0.7
—
0
6
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
67
1.05
0.08
1.1
1.3
nmol/l
0.6
0.6
—
7
59
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
108
1.11
0.07
2.1
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
89
1.13
0.07
2.0
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
99
1.11
0.06
1.2
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
49
474
1.04
0.06
1.9
2.4
ug/l
4.2
7.0
1.54
42
410
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
10
102
0.98
0.00
1.8
1.9
nmol/l
44.5
42.6
—
10
96
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
73.9
—
0
8
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
136
1360
1.00
0.00
4.0
3.8
%
20.4
23.9
2.12
66
645
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
210
1.00
0.00
1.3
1.9
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
87
0.92
0.00
1.3
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
6.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
83
0.96
0.00
1.6
1.9
pmol/l
226.4
231.3
—
8
75
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
26.0
—
0
5
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
53
0.94
0.00
1.4
1.2
mmol/l
7.0
7.8
—
5
37
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MARGINAL_ZONE_LYMPHOMA_EXALLC – Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).